Gyre Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GYRE and other ETFs, options, and stocks.About GYRE
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis).
GYRE Key Statistics
Stock Snapshot
Gyre Therapeutics(GYRE) stock is priced at $7.01, giving the company a market capitalization of 637.6M. It carries a P/E multiple of 340.00.
On 2026-03-18, Gyre Therapeutics(GYRE) stock traded between a low of $7.01 and a high of $7.60. Shares are currently priced at $7.01, which is 0.0% above the low and -7.8% below the high.
The Gyre Therapeutics(GYRE)'s current trading volume is 188.88K, compared to an average daily volume of 160.17K.
During the past year, Gyre Therapeutics(GYRE) stock moved between $6.11 at its lowest and $11.78 at its peak.
During the past year, Gyre Therapeutics(GYRE) stock moved between $6.11 at its lowest and $11.78 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.